Hongbo Lu, Director at Terns Pharmaceuticals, Inc. (TERN), bought 3,747,260 shares at $2.98 ($10.3M) on 2022-08-12, disclosed to the SEC on 2022-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.98 | 1,123,021 | $3.3M | 32.4% |
| 2 | $2.98 | 1,123,021 | $3.3M | 32.4% |
| 3 | $2.99 | 1,218 | $4K | 0.0% |
| 4 | $2.42 | 1,500,000 | $3.6M | 35.2% |
| Total | $2.76 avg | 3,747,260 | $10.3M | 100% |
| Filing → |
| ZBIO | BUY | 2026-03-31 | $1.5M | — | Filing → |
| ZBIO | BUY | 2026-02-13 | $585K | — | Filing → |
| ZBIO | BUY | 2025-10-09 | $5.0M | — | Filing → |